Salisbury Foundation Trust

FOI_6396

Internal Reference Number: FOI_6396

Date Request Received: 10/12/2021 00:00:00

Date Request Replied To: 04/01/2022 00:00:00

This response was sent via: By Email

Request Summary: Treatment of Ovarian cancer

Request Category: Companies

 
Question Number 1:
How many patients have been treated for advanced (FIGO Stages III and IV) high-grade ovarian (epithelial ovarian, fallopian tube or primary peritoneal) cancer over the last 3 months?
If none, do you refer ovarian cancer patients to another trust, if so which one?
 
Answer To Question 1:
4 patients
 
Question Number 2:
How many ovarian cancer patients (any stage) have been treated in the last 3 months with:
• Paclitaxel in combination with a platinum-based compound
• Platinum-based therapy alone (cisplatin or carboplatin)
• Bevacizumab in combination with paclitaxel and carboplatin
• Olaparib
• Olaparib + Bevacizumab
• Niraparib
• Rucaparib
 
Answer To Question 2:
• Paclitaxel with platinum 9
• Platinum alone 7
• Bevacizumab with paclitaxel/carboplatin 5
• Olaparib 0
• Olaparib+ bev 0
• Niraparib 5
• Rucaparib 1
 
Question Number 3:
Of the ovarian cancer patients (any stage) treated over the last 3 months, how many patients:
• Received HRD (homologous recombination deficiency) testing
• Received BRCA testing
• Tested HRD positive
• Tested BRCA positive (BRCAm)
 
Answer To Question 3:
• Received HRD testing: 8
• Received BRCA testing: 19
• Tested HRD positive: 0
• Tested BRCA positive: 1
 
Question Number 4:
If data for HRD testing is available, please provide how many HRD positive patients were treated in the last 3 months with:
• Olaparib
• Olaparib + Bevacizumab
• Niraparib
• Other treatments
 
Answer To Question 4:
0
 
Question Number 5:
If data for HRD and BRCA testing is available, please provide how many HRD positive-BRCA positive patients were treated in the last 3 months with:
• Olaparib
• Olaparib + Bevacizumab
• Niraparib
• Other treatments
 
Answer To Question 5:
• 1 patient – ‘other treatment’ treated with carboplatin/paclitaxel
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2022 Salisbury NHS Foundation Trust
Trust Values